Covovax Paedriatic Trials to Begin at Pune Site from Monday; Study Aims to Check Immune Response in Kids
In 2020, US-based vaccine maker Novovax Inc had announced a licence agreement with the Covishield manufacture- Serum Institute of India (SII) for the development and commercialisation of its Covid-19 vaccine Covovax.
Source: Top India News- News18.com